GE soars on $21.4B sale of bio-pharma business to Danaher

GENERAL ELECTRIC CO. has sold its bio-pharma business to Danaher Corp. for $21.4 billion. / BLOOMBERG NEWS FILE PHOTO/DANIEL ACKER
GENERAL ELECTRIC CO. has sold its bio-pharma business to Danaher Corp. for $21.4 billion. / BLOOMBERG NEWS FILE PHOTO/DANIEL ACKER
NEW YORK - General Electric Co. surged as much as 19 percent after agreeing to sell its bio-pharma business to Danaher Corp. for $21.4 billion, a transformative step in the new CEO’s effort to rescue the troubled behemoth. GE halted plans to spin off its broader health-care business as it focuses on completing the deal,…

Register to keep reading or subscribe today and receive unlimited access.
Register Now Already a Subscriber? Login now

If you have already logged in and are still seeing this message, please refresh the page as your browser is caching the old content.

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

No posts to display